A first-of-its-kind vaccine against cancer may be on the horizon.

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...

Key Takeaways A personalized cancer vaccine significantly improves survival odds for people with melanomaPatients were 42% ...

If we want cancer vaccines to reach patients faster than BRCA testing did, there are several challenges to address now,” ...

Drugs giant GSK has seen shares come under pressure as falling vaccine sales overshadowed a better-than-forecast rise in ...

A new narrative review finds no licensed treatment or vaccine exists for Marburg virus disease as investigational antibodies, ...

The FDA-approved mRNA flu shot is now available at some Billings pharmacies, including CVS and Albertson's, though several ...

Last fall, FDA safety officers began compiling a list of children possibly killed by COVID vaccines. Digging through thousands of reports of adverse effects and autopsy records of those who had died ...

A new review finds that mRNA vaccines and host-directed therapeutics for multidrug-resistant ESKAPE bacteria remain ...

Hello, everyone, and welcome to Health Brief. If you’re interested in the release of a Labor Department rule that would ...

But a modified intent-to-treat analysis showed a noninferior vaccine efficacy rate ...

Panmure Liberum believes positive Phase 3 data for a cancer vaccine developed by Moderna and Merck supports the scientific rationale behind Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the ...